Evogliptin
2016-08-144
Phase 2 small_molecule completed
Quick answer
Evogliptin for Type2 Diabetes Mellitus is a Phase 2 program (small_molecule) at Samsung Bioepis NL B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Samsung Bioepis NL B.V.
- Indication
- Type2 Diabetes Mellitus
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed